Viatris Inc. Common Stock (VTRS) — Analysis Summary
Viatris Inc. Common Stock (VTRS) has a market cap of $18.77B with year-over-year revenue growth of -3.0%. Net margin stands at -24.7%. The stock trades at a P/E ratio of -45.7.
Key Takeaways
- Revenue changed -3.0% year-over-year
- Net margin of -24.7%
- P/E ratio of -45.7
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, VTRS posted revenue growth of -3.0% and trades at a P/E of -45.7.
Viatris Inc. Common Stock (VTRS)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -0.2x — earnings do not cover interest payments
Debt/EBITDA at 4.9x — elevated leverage
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
Sector
PHARMACEUTICAL PREPARATIONS
Employees
30,000
Headquarters
CANONSBURG, PA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$0.48
Dividend Yield
2.94%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.